Research and News

Witt and Morlock join Arbor Research Board of Directors
Arbor Research Collaborative for Health is pleased to announce that its Board of Directors has elected two new members for terms starting in January 2019. Read more... 

Arbor Research Creates Free App to Empower Kidney Disease Patient Self-care
Arbor Research Collaborative for Health, in partnership with NephCure Kidney International and Children's Hospital of Philadelphia, has created a smartphone-based application to boost self-care by patients with a range of kidney and renal disorders. Read more... 

Arbor Research Wins Access to $1.6 billion in Funding for Measure and Instrument Development
The Centers for Medicare & Medicaid Services (CMS) recently selected Arbor Research Collaborative for Health as one of 31 organizations across the United States to carry out up to $1.6 billion in contract work related to health care quality measurement over the next decade. Read more... 

Uptake of Generic vs Brand Name Immunosuppressants Among US Organ Transplant Recipients
After an organ transplant, a transplant recipient must take immunosuppressive medications to reduce the risk of their body rejecting the transplanted organ. Although using therapeutically equivalent generic medications can reduce financial burden, the transplant community has expressed caution about substituting these for brand-name immunosuppressants. Read more... 

Study of self-reported symptom clusters may improve the diagnosis and treatment of women with LUTS
Currently, women with lower urinary tract symptoms (LUTS) are treated according to their most troubling symptom. This approach is not always completely successful, as it does not take into account that patients can have multiple symptoms that respond to different treatments. Read more...